Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months

被引:43
作者
Liu, L
Hu, H
Ji, HZ
Murdin, AD
Pierce, GN
Zhong, GM
机构
[1] Univ Manitoba, St Boniface Gen Hosp, Res Ctr, Dept Med Microbiol, Winnipeg, MB R3T 2N2, Canada
[2] Univ Manitoba, St Boniface Gen Hosp, Res Ctr, Dept Physiol, Winnipeg, MB R3T 2N2, Canada
[3] Univ Manitoba, St Boniface Gen Hosp, Res Ctr, Div Stroke & Vasc Dis, Winnipeg, MB R3T 2N2, Canada
[4] Aventis Pasteur Canada, N York, ON, Canada
基金
英国医学研究理事会;
关键词
chlamydial exacerbation of atherosclerosis;
D O I
10.1023/A:1026531506202
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously shown that infection with the C. pneumoniae AR39 strain once monthly for 9 consecutive months significantly exacerbated atherosclerosis in mice with LDL receptor deficiency (LDLR-/-) in the presence of a high cholesterol diet. To further optimize the LDLR-/- mouse model for studying the mechanisms of C. pneumoniae atherogenesis, we have tested a different infection protocol with intranasal inoculation twice monthly for 6 consecutive months in the present study. We found that C. pneumoniae infection for 6 months was sufficient to produce a 130%, significantly greater exacerbation of aortic atherosclerosis in LDLR-/- mice in the presence of a high cholesterol diet. Mice receiving a high cholesterol diet alone displayed a lesion area index of 18.2 +/- 6.1 (S.D.) while mice treated with both the high cholesterol diet and C. pneumoniae infection had a lesion area index of 41.8 +/- 15.2 (S.D.). However, the chlamydial infection did not significantly alter the mouse serum total cholesterol or the LDL levels induced by the high cholesterol diet. This study not only confirms our previous findings that C. pneumoniae infection can exacerbate aortic atherosclerosis lesion in the LDLR-/- mice, but also further optimizes the LDLR-/- mouse model for future mechanism studies.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 41 条
  • [1] Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
    Aiello, RJ
    Bourassa, PAK
    Lindsey, S
    Weng, WF
    Natoli, E
    Rollins, BJ
    Milos, PM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) : 1518 - 1525
  • [2] Aji W, 1997, CIRCULATION, V95, P430
  • [3] Bird DA, 1998, J LIPID RES, V39, P1079
  • [4] Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
    Boring, L
    Gosling, J
    Cleary, M
    Charo, IF
    [J]. NATURE, 1998, 394 (6696) : 894 - 897
  • [5] Chlamydia pneumoniae and atherosclerosis:: Links to the disease process
    Byrne, GI
    Kalayoglu, MV
    [J]. AMERICAN HEART JOURNAL, 1999, 138 (05) : S488 - S490
  • [6] Mouse models of Chlamydia pneumoniae infection and atherosclerosis
    Campbell, LA
    Kuo, CC
    [J]. AMERICAN HEART JOURNAL, 1999, 138 (05) : S516 - S518
  • [7] Chlamydia pneumoniae and cardiovascular disease
    Campbell, LA
    Kuo, CC
    Grayston, JT
    [J]. EMERGING INFECTIOUS DISEASES, 1998, 4 (04) : 571 - 579
  • [8] P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice
    Collins, RG
    Velji, R
    Guevara, NV
    Hicks, MJ
    Chan, L
    Beaudet, AL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (01) : 189 - 194
  • [9] Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205
  • [10] Rabbit model for Chlamydia pneumoniae infection
    Fong, IW
    Chiu, B
    Viira, E
    Fong, MW
    Jang, D
    Mahony, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) : 48 - 52